Kirby (KEX) Q2 EPS Jumps 17%
GAAP earnings per share reached $1.67 in Q2 2025, edging past GAAP estimates and up 17% year-over-year (GAAP).
GAAP revenue climbed to $855.5 million in Q2 2025, slightly topping GAAP expectations and increasing 3.8% from the prior year.
Management highlighted caution for the rest of 2025, guiding toward the lower end of prior full-year 2025 earnings growth target.
These 10 stocks could mint the next wave of millionaires ›
Kirby (NYSE:KEX), a leading U.S. tank barge operator and diversified industrial services provider, posted its latest earnings on July 31, 2025, covering the quarter. The company reported GAAP earnings per share of $1.67, just above analyst expectations of $1.66 (GAAP). Total GAAP revenue reached $855.5 million, surpassing GAAP consensus by $2.99 million. Both GAAP net earnings per share and revenue were higher than in Q2 2024. The quarter showed margin and topline improvement, but management took a more cautious tone for the remainder of 2025, noting trade and demand uncertainties. Overall, the period reflected disciplined execution despite signals of emerging softness in some markets.
Metric Q2 2025 Q2 2025 Estimate Q2 2024 Y/Y Change
EPS (GAAP) $1.67 $1.66 $1.43 17%
Revenue (GAAP) $855.5 million $852.5 million $824.4 million 3.8%
Operating Margin (GAAP) 15.4% 14.6% 0.8 pp
EBITDA $202.2 million $182.9 million 10.6%
Free Cash Flow $22.5 million $90.7 million (75.2%)
Source: Analyst estimates provided by FactSet. Management expectations based on management's guidance, as provided in Q1 2025 earnings report.
Company Profile and Business Drivers
Kirby is the dominant operator in the U.S. tank barge sector, holding about 27% of the inland market as of December 31, 2024 and 11% of the coastal market as of December 31, 2024 through a fleet of over 1,100 inland and 28 coastal tank barges. Its operations span marine transportation of bulk liquids and a distribution and services unit that delivers industrial equipment repair and parts.
The company's main success factors include scale in marine services, alignment with strict regulatory standards, and diversification into industrial equipment sales and servicing. Demand for products like petrochemicals and petroleum, tight shipyard capacity, and compliance with rules from the U.S. Coast Guard are key for ongoing performance. In recent years, initiatives have focused on upgrading vessel compliance, investing in ballast water systems, and balancing segment earnings through industrial and power generation projects.
Quarter Highlights: Financial and Operating Performance
The second quarter marked another period of performance slightly above consensus for both GAAP revenue and earnings per share. Revenue increased 3.8% compared to the prior year, while GAAP earnings per share advanced 17% year over year. EBITDA (non-GAAP) also climbed, supported by efficiency and steady customer volumes.
In the Marine Transportation segment, Marine transportation revenue rose 1.6% to $492.6 million compared to Q2 2024. Marine transportation operating income increased 4.4% compared to Q2 2024, with margins reaching 20.1% (GAAP), up from 19.6% (GAAP) in Q2 2024. The inland tank barge business (81% of the segment) maintained high barge utilization in the low to mid-90% range. Spot and term contract pricing both edged higher year-over-year. In the coastal segment (19% of segment revenue), utilization was in the mid to high-90% range, and term renewals climbed mid-20% from the prior year. However, Fuel costs per gallon dropped to $2.35 from $2.83 in Q2 2024.
Distribution and Services revenue saw broader improvement. Distribution and Services revenue was $362.9 million, up 6.9% compared to Q2 2024. This segment includes product lines such as power generation equipment, commercial and industrial engines, and oil and gas field service. Power generation revenue jumped 31% year-over-year on continued demand from data centers and manufacturing. The commercial and industrial group posted 5% revenue growth and a 24% increase in operating income. Oil and gas revenue fell 27% year-over-year due to weaker demand, but operating income rose sharply as the company focused on high-margin electric hydraulic fracturing (e-frac) equipment sales and cost management initiatives. Segment operating margin landed at 9.8%, up from 8.7% in Q2 2024. Management highlighted a mixed near-term picture for sales in this unit, with full-year 2025 revenues projected to be 'flat to slightly up.'
Other notable financial developments included a sharp decline in free cash flow, down to $22.5 million from $90.7 million (non-GAAP) versus Q2 2024. Operating cash flow (GAAP) dropped by almost half to $94.0 million compared to Q2 2024, while GAAP capital expenditures decreased compared to Q2 2024. During the quarter, the company repurchased 331,900 shares for $31.2 million, citing continued capital discipline. Debt increased to $1,117.8 million as of June 30, 2025, raising the total debt-to-capitalization ratio to 24.8% as of June 30, 2025, from 20.7% at December 31, 2024. Liquidity stood at $68.4 million in cash and $331.5 million available overall as of June 30, 2025.
No significant one-time events were itemized for this report. However, navigation and lock delays, as well as elevated planned shipyard activity, constrained efficiency, particularly in the marine units. There was no update to dividend policy as the company continued its practice of not paying a dividend this quarter. KEX does not currently pay a dividend.
Business Model and Industry Dynamics
Kirby's performance is tied closely to its marine transportation fleet and the regulatory landscape. The Jones Act, which restricts waterborne cargo shipments between U.S. ports to U.S.-built and -crewed vessels, protects the tank barge industry from foreign competition. Meeting requirements from the U.S. Coast Guard (USCG) and the American Bureau of Shipping (ABS) ensures fleet eligibility but comes with high compliance and upgrade costs. The company maintains its edge through ongoing investments.
Kirby's fleet flexibility enables it to respond to swings in petrochemical and petroleum product demand. Many barges can be switched between carrying chemicals and refined products, providing resilience when individual markets shift. The industry is marked by high steel prices, making it costly to build new barges—currently about $4.7 million for a 30,000-barrel model, as stated by management in Q1 2025. This cost, alongside ongoing labor shortages for mariners, limits rapid fleet expansion. Orders observed in the sector remain largely for replacement rather than growth, suggesting fleet numbers will remain flat or decline in 2025.
Looking Forward: Guidance and Watch Points
For fiscal 2025, management reiterated guidance for 15% to 25% earnings per share growth in FY2025. However, its commentary shifted to a more cautious stance, warning that continued softness in short-term demand or extended trade challenges could result in outcomes 'closer to the lower end' of the prior full-year EPS growth guidance range of 15% to 25% for 2025. Marine transportation, especially inland barge utilization, is expected to dip into the low 90% range in Q3 2025. Segment margins are projected to stabilize around 20% inland and in the mid-to-high teens for coastal operations in Q2 2025.
In Distribution and Services, leadership expects FY2025 revenue to be flat or up slightly, with operating margin in the 'high single digits.' Longer OEM lead times, trade policy developments, and labor inflation are all highlighted as ongoing challenges. Liquidity remains solid, but the sharp contraction in free cash flow (non-GAAP) and the increased debt-to-capitalization ratio in Q2 2025 are watch points for capital allocation, future acquisitions, and elevated capital expenditures.
Revenue and net income presented using U.S. generally accepted accounting principles (GAAP) unless otherwise noted.
Where to invest $1,000 right now
When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,036%* — a market-crushing outperformance compared to 181% for the S&P 500.
They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor.
See the stocks »
*Stock Advisor returns as of July 29, 2025
JesterAI is a Foolish AI, based on a variety of Large Language Models (LLMs) and proprietary Motley Fool systems. All articles published by JesterAI are reviewed by our editorial team, and The Motley Fool takes ultimate responsibility for the content of this article. JesterAI cannot own stocks and so it has no positions in any stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy.
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Globe and Mail
25 minutes ago
- Globe and Mail
Tevogen.AI Expands Collaboration With Databricks and Microsoft to Build the Beta Version of Its PredicTcell™ Model With a Focus on Oncology
to explore external market opportunities as a potential revenue source. Beta version to incorporate oncology targets, enhancing the accuracy and diversity of the PredicTcell model and potentially accelerating cancer immunotherapy development. to develop enhanced analytics and visualization tools, for the PredicTcell model to support its internal R&D teams. WARREN, N.J., Aug. 05, 2025 (GLOBE NEWSWIRE) -- Tevogen ('Tevogen Bio Holdings Inc.' or 'Company') (Nasdaq: TVGN) today announced that its artificial intelligence initiative, is expanding its collaboration with Microsoft (Nasdaq: MSFT) and Databricks, to build the beta version of its foundational PredicTcell model. Powered by the Databricks Data Intelligence Platform and backed by their innovative engineering teams, has begun curating a dataset focused on oncology. The dataset, aggregated with the initial virology dataset. aims to improve upon the accuracy of the alpha version of PredicTcell model. This next phase of development builds on recently published international patent application (WO 2025/129197), which outlines novel machine learning systems for predicting immunologically active peptides, a critical step in developing targeted therapies for cancers and infectious diseases. 'We have been extremely fortunate to work with such great organizations like Microsoft and Databricks to build the alpha version of our foundational AI model,' said Mittul Mehta, Chief Information Officer and Head of 'Oncology represents one of the most impactful areas for AI in drug discovery, given the complexity of the disease and the limited availability of high-quality datasets.' Forward Looking Statements This press release contains certain forward-looking statements, including without limitation statements relating to: Tevogen's plans for its research and manufacturing capabilities; expectations regarding future growth; expectations regarding the healthcare and biopharmaceutical industries; and Tevogen's development of, the potential benefits of, and patient access to its product candidates for the treatment of infectious diseases and cancer. Forward-looking statements can sometimes be identified by words such as 'may,' 'could,' 'would,' 'expect,' 'anticipate,' 'possible,' 'potential,' 'goal,' 'opportunity,' 'project,' 'believe,' 'future,' and similar words and expressions or their opposites. These statements are based on management's expectations, assumptions, estimates, projections and beliefs as of the date of this press release and are subject to a number of factors that involve known and unknown risks, delays, uncertainties and other factors not under the company's control that may cause actual results, performance or achievements of the company to be materially different from the results, performance or other expectations expressed or implied by these forward-looking statements. Factors that could cause actual results, performance, or achievements to differ from those expressed or implied by forward-looking statements include, but are not limited to: that Tevogen will need to raise additional capital to execute its business plan, which may not be available on acceptable terms or at all; changes in the markets in which Tevogen competes, including with respect to its competitive landscape, technology evolution, or regulatory changes; changes in domestic and global general economic conditions; the risk that Tevogen may not be able to execute its growth strategies or may experience difficulties in managing its growth and expanding operations; the risk that Tevogen may not be able to develop and maintain effective internal controls; the failure to achieve Tevogen's commercialization and development plans and identify and realize additional opportunities, which may be affected by, among other things, competition, the ability of Tevogen to grow and manage growth economically and hire and retain key employees; the risk that Tevogen may fail to keep pace with rapid technological developments to provide new and innovative products and services or make substantial investments in unsuccessful new products and services; risks related to the ability to develop, license or acquire new therapeutics; the risk of regulatory lawsuits or proceedings relating to Tevogen's business; uncertainties inherent in the execution, cost, and completion of preclinical studies and clinical trials; risks related to regulatory review, approval and commercial development; risks associated with intellectual property protection; Tevogen's limited operating history; and those factors discussed or incorporated by reference in Tevogen's Annual Report on Form 10-K. You should not place undue reliance on forward-looking statements, which speak only as of the date they are made. Tevogen undertakes no obligation to update any forward-looking statements, except as required by applicable law.
Globe and Mail
25 minutes ago
- Globe and Mail
5 Reasons to Buy D-Wave Stock Like There's No Tomorrow
D-Wave (NYSE: QBTS) is up 120% in 2025, driven by momentum involving its Advantage2 system and a major capital raise. But with negative cash flow and dilution concerns, is it the next tech rocket or a risky bet? I'll break down the facts so you can decide before Wall Street catches up. *Stock prices used were the market prices of Aug. 4, 2025. The video was published on Aug. 5, 2025. Where to invest $1,000 right now? Our analyst team just revealed what they believe are the 10 best stocks to buy right now. Continue » Where to invest $1,000 right now When our analyst team has a stock tip, it can pay to listen. After all, Stock Advisor's total average return is 1,039%* — a market-crushing outperformance compared to 181% for the S&P 500. They just revealed what they believe are the 10 best stocks for investors to buy right now, available when you join Stock Advisor. See the stocks » *Stock Advisor returns as of August 4, 2025 Rick Orford has no position in any of the stocks mentioned. The Motley Fool has no position in any of the stocks mentioned. The Motley Fool has a disclosure policy. Rick Orford is an affiliate of The Motley Fool and may be compensated for promoting its services. If you choose to subscribe through their link, they will earn some extra money that supports their channel. Their opinions remain their own and are unaffected by The Motley Fool.
Globe and Mail
25 minutes ago
- Globe and Mail
The 3 Best Warren Buffett Stocks to Buy Right Now
Key Points You can find wealth-building investments by perusing Berkshire Hathaway's well-stocked portfolio. Three of Buffett's most defensive stocks are particularly attractive buys today. 10 stocks we like better than Berkshire Hathaway › All good things must come to an end. After six decades generating fortunes for Berkshire Hathaway 's (NYSE: BRK.A)(NYSE: BRK.B) shareholders, Warren Buffett will soon relinquish his role as CEO of the trillion-dollar masterpiece of American capitalism he helped build. Fortunately, Buffett plans to remain chairman of Berkshire's Board of Directors and continue to help guide the company's major investment decisions. Better still, the legendary financier's best ideas continue to comprise the lion's share of the conglomerate's public stock holdings, currently valued at a staggering $280 billion. If you'd like to profit alongside Buffett, here are some of Berkshire's best stocks for today's turbulent economic environment. 1. Kroger When people pinch pennies, they dine out less and dine in more. The eat-from-home trend is a boon for Kroger (NYSE: KR), the largest pure play grocery chain in the U.S. With over 2,700 stores and roughly $150,000 billion in annual revenue, Kroger's impressive scale provides it with significant advantages over its smaller rivals. The grocery giant's purchasing power gives it an edge in pricing that cash-strapped consumers appreciate. Kroger can also afford to invest more aggressively in technology, which helped to fuel a 15% jump in the company's digital sales in the first quarter. All told, Kroger is the type of investment that will allow you to sleep easily at night while you own it. People need to eat, and the grocery leader's defensive business model generates consistent profits across economic cycles. Moreover, Kroger's bountiful free cash flow -- which management expects to climb as high as $3 billion in 2025 -- supports a steadily growing dividend and sizable share repurchases. These cash returns should continue to drive Kroger's stock price higher in the coming years. KR data by YCharts. 2. Coca-Cola Long-time Buffett favorite Coca-Cola (NYSE: KO) is another reliable dividend stock to consider adding to your diversified investment portfolio. The beverage colossus has increased its cash payments to shareholders for an extraordinary 63 consecutive years. If you're worried about Coca-Cola's reliance on sugary soda sales, fear not. The beverage king has worked to broaden its offerings to include healthier fare like milk, tea, and bottled water. Strong sales of high-protein drinks under the company's popular Fairlife brand are a notable growth driver. Coca-Cola Zero Sugar and other sugar-free drinks also remain top sellers among health-conscious consumers. Coca-Cola's diversified product lineup and strong free-cash-flow generation make it one of the most dependable dividend payers available in the stock market today. Buffett's beloved beverage maker is currently offering you a solid 3% yield. 3. Berkshire Hathaway The most defensive and safest business of all, however, may just be Berkshire Hathaway itself. Buffett's financial fortress is sitting on a massive cash stash of more than $340 billion just waiting to be deployed in value-creating investments on behalf of its shareowners. Berkshire's huge cash reserves enable it to pounce on profit opportunities as they arise. This typically occurs during volatile times. Buffett fans know this, which is one of the reasons why Berkshire's stock tends to outperform during bear markets. The megaconglomerate's diverse business segments further help to reduce the risks for investors. Berkshire owns more than 60 operating subsidiaries in areas as far-ranging as railroads, car insurance, ice cream, and underwear. BNSF Railway, GEICO, Dairy Queen, and Fruit of the Loom are just a small sample of Berkshire's assorted holdings. Together, these businesses cranked out over $10 billion in operating cash flow in Q1 alone. Although Buffett is stepping down as CEO at the end of 2025, he's handing over the reins to his hand-picked successor, Greg Abel. The longtime Berkshire executive isn't expected to rock the boat, as he's already overseeing many of the company's most important businesses. And the limited number of changes expected to come under Abel's leadership could prove beneficial. For example, Abel might be more aggressive with selling off Berkshire's few underperforming assets, such as its multibillion-dollar stake in Kraft Heinz. That could further swell the investment giant's already enormous cash reserves, thereby giving Berkshire even more capital to deploy during the next market downturn. Should you invest $1,000 in Berkshire Hathaway right now? Before you buy stock in Berkshire Hathaway, consider this: The Motley Fool Stock Advisor analyst team just identified what they believe are the 10 best stocks for investors to buy now… and Berkshire Hathaway wasn't one of them. The 10 stocks that made the cut could produce monster returns in the coming years. Consider when Netflix made this list on December 17, 2004... if you invested $1,000 at the time of our recommendation, you'd have $631,505!* Or when Nvidia made this list on April 15, 2005... if you invested $1,000 at the time of our recommendation, you'd have $1,103,313!* Now, it's worth noting Stock Advisor's total average return is 1,039% — a market-crushing outperformance compared to 181% for the S&P 500. Don't miss out on the latest top 10 list, available when you join Stock Advisor. See the 10 stocks » *Stock Advisor returns as of August 4, 2025
